Last Friday the stand was executed at Johnson & Johnson vaccination Against COVID-19. Application of the drug has been suspended for approximately two weeks, following a recommendation by the CDC (Centers for Disease Control and Prevention) and FDA (United States Food and Drug Administration) that requested suspension Application temporarily Of this vaccine, after reports of blood clots in half a dozen of the women who received it And deceased. Then the adverse cases increased to 15.
Health security agencies that conducted the investigation Vaccine risks Johnson & Johnson found that after a “comprehensive safety review,” they confirmed the drug’s reliability and effectiveness, after evaluating the data.
This was announced by the US Food and Drug Administration, Through a press releaseWhere they shed light on it
Reported blood clots have been found in patients receiving Johnson & Johnson vaccinations These are very rare events.
“After a comprehensive safety review, including two meetings of the CDC’s Immunization Practices Advisory Committee, the US Food and Drug Administration, and the US Centers for Disease Control and Prevention. I decided that the recommended temporary discontinuation regarding use of Johnson & Johnson (Janssen) should be lifted. “The use of the vaccine must be resumed,” the Food and Drug Administration said in its announcement.
The Federal Agency added:
During the break, medical and scientific teams from the Food and Drug Administration (FDA) and the Center for Disease Control (CDC) reviewed the data available to assess the risk of blood clots affecting cerebral venous sinuses or CVSTs (the large blood vessels in the brain) and other sites in the body (including In it, among other things, to large blood vessels in the abdomen and leg veins) along with thrombocytopenia or low platelet count. The FDA team and the Centers for Disease Control and Prevention (CDC) have also conducted extensive outreach to service providers. And physicians to ensure they are aware of the potential for these adverse events and are able to manage and recognize them properly due to the unique treatment required for these blood clots and low platelet count, also known as thrombotic-thrombocytopenia syndrome (TTS). ”
The CDC joined the announcement, and with the Food and Drug Administration, not only did they say that the use of the Johnson & Johnson vaccine should be resumed in the United States, and that they were confident that it was “safe and effective,” but they cautioned that “the known and potential benefits of the vaccine outweigh its known and potential risks.” In people over the age of 18.
However, despite insisting that the likelihood of thrombosis and thrombosis is extremely low, both the Food and Drug Administration and the CDC will continue to closely monitor any relevant reports.
“Safety is our top priority. This gap was an example of our extensive work in security surveillance, as it was designed to work, identifying even this small number of cases.” Said Janet Woodcock, Acting FDA Commissioner, We have lifted the pause based on a review The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) for all available data and in consultation with medical experts and based on the recommendations of the Centers for Disease Control and Prevention (CDC) Advisory Committee on immunization practices.
“We have concluded that the known and potential benefits of the J&J COVID-19 vaccine outweigh its known and potential risks in people 18 years of age or older. We are confident that this vaccine continues to meet our standards for safety, efficacy and quality. We encourage people with questions. About the appropriate vaccine for them to speak with their healthcare provider, “the official added.
Rochelle B Wallinsky, director of the Centers for Disease Control and Prevention, stressed that health and safety are the science that guides their decisions, and urged Americans to trust the Johnson & Johnson vaccine.
Why stop using the Johnson & Johnson vaccine? We explain it to you | Telemundo NewsOfficial video from Noticias Telemundo. Six blood clots have been detected among more than 6.8 million people who have received a single dose of this vaccine against COVID-19. Experts note that its effect is “extremely rare” and say vaccines are still safe. Download our app: telemundo.app.link/8005Db9UP6 Subscribe: bit.ly/TLMDNoticiasYT Noticias Noticias …2021-04-13T21: 29: 33Z
“Our vaccine safety systems are working. We identified exceptionally rare events, out of the millions of doses taken, and stopped to closely examine them. As we always do, we will continue to closely monitor all signs as more Americans are vaccinated,” said the CDC chief . “I remain encouraged by the growing number of factual evidence that licensed COVID-19 vaccines are safe and effective, protecting people from disease, hospitalization, and death.”
If you have received a Johnson & Johnson vaccine, you should pay attention to these symptomsThe United States has discontinued the application of the Johnson & Johnson coronavirus vaccine after six women had rare blood clots. That is why specialists advise those who have been immunized with a dose of this company to be alert in case of headache or chest pain, difficulty in …2021-04-14T05: 04: 22Z
The Johnson & Johnson vaccine application discontinuation came after 6 cases of stroke were reported out of more than 6.8 million doses administered. Reports went up to 15 years, and they all occurred in women between the ages of 18 and 59 who developed negative symptoms 6 to 15 days after receiving the vaccine.